Clinically, aberrant RIPK1 signaling is associated with inflammatory conditions such as IBD, where it regulates the transition of NF-κB signaling from cell survival to apoptosis or necroptosis [9, 10]. The gene discussed is NFKB1; the disease is inflammatory bowel disease.